Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Hepatitis A Vaccine Market 2018, Forecast to 2023

Publisher Name :
Date: 13-Aug-2018
No. of pages: 135

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

Two types of HAV vaccines are currently available internationally:

1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.

Scope of the Report:

This report focuses on the Hepatitis A Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.

The classification of Hepatitis A Vaccine includes Inactivated Vaccine, Live Attenuated Vaccine, and the sales proportion of Inactivated Vaccine in 2017 is about 70.8%, and the proportion is increasing trend from 2013 to 2018.

Inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).

The worldwide market for Hepatitis A Vaccine is expected to grow at a CAGR of roughly 2.8% over the next five years, will reach 770 million US$ in 2023, from 650 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- GSK

- Merck

- Sanofi

- Sinovac

- Zhejiang Pukang

- Changchun Institute of Biological

- Kaketsuken

- IMBCA

- ChangSheng

- Convac

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Inactivated Vaccine

- Live Attenuated Vaccine

Market Segment by Applications, can be divided into

- Government Institution

- Private Sector

- Other

There are 15 Chapters to deeply display the global Hepatitis A Vaccine market.

Chapter 1, to describe Hepatitis A Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Hepatitis A Vaccine, with sales, revenue, and price of Hepatitis A Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Hepatitis A Vaccine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Hepatitis A Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Hepatitis A Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Hepatitis A Vaccine Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Hepatitis A Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Inactivated Vaccine
1.2.2 Live Attenuated Vaccine
1.3 Market Analysis by Applications
1.3.1 Government Institution
1.3.2 Private Sector
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 Business Overview
2.1.1.1 GSK Description
2.1.1.2 GSK Headquarter, Main Business and Finance Overview
2.1.2 GSK Hepatitis A Vaccine Product Introduction
2.1.2.1 Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
2.1.2.2 Hepatitis A Vaccine Product Information
2.1.3 GSK Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 GSK Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global GSK Hepatitis A Vaccine Market Share in 2017
2.2 Merck
2.2.1 Business Overview
2.2.1.1 Merck Description
2.2.1.2 Merck Headquarter, Main Business and Finance Overview
2.2.2 Merck Hepatitis A Vaccine Product Introduction
2.2.2.1 Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
2.2.2.2 Hepatitis A Vaccine Product Information
2.2.3 Merck Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Merck Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Merck Hepatitis A Vaccine Market Share in 2017
2.3 Sanofi
2.3.1 Business Overview
2.3.1.1 Sanofi Description
2.3.1.2 Sanofi Headquarter, Main Business and Finance Overview
2.3.2 Sanofi Hepatitis A Vaccine Product Introduction
2.3.2.1 Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
2.3.2.2 Hepatitis A Vaccine Product Information
2.3.3 Sanofi Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Sanofi Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Sanofi Hepatitis A Vaccine Market Share in 2017
2.4 Sinovac
2.4.1 Business Overview
2.4.1.1 Sinovac Description
2.4.1.2 Sinovac Headquarter, Main Business and Finance Overview
2.4.2 Sinovac Hepatitis A Vaccine Product Introduction
2.4.2.1 Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
2.4.2.2 Hepatitis A Vaccine Product Information
2.4.3 Sinovac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Sinovac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Sinovac Hepatitis A Vaccine Market Share in 2017
2.5 Zhejiang Pukang
2.5.1 Business Overview
2.5.1.1 Zhejiang Pukang Description
2.5.1.2 Zhejiang Pukang Headquarter, Main Business and Finance Overview
2.5.2 Zhejiang Pukang Hepatitis A Vaccine Product Introduction
2.5.2.1 Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
2.5.2.2 Hepatitis A Vaccine Product Information
2.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Zhejiang Pukang Hepatitis A Vaccine Market Share in 2017
2.6 Changchun Institute of Biological
2.6.1 Business Overview
2.6.1.1 Changchun Institute of Biological Description
2.6.1.2 Changchun Institute of Biological Headquarter, Main Business and Finance Overview
2.6.2 Changchun Institute of Biological Hepatitis A Vaccine Product Introduction
2.6.2.1 Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
2.6.2.2 Hepatitis A Vaccine Product Information
2.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Changchun Institute of Biological Hepatitis A Vaccine Market Share in 2017
2.7 Kaketsuken
2.7.1 Business Overview
2.7.1.1 Kaketsuken Description
2.7.1.2 Kaketsuken Headquarter, Main Business and Finance Overview
2.7.2 Kaketsuken Hepatitis A Vaccine Product Introduction
2.7.2.1 Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
2.7.2.2 Hepatitis A Vaccine Product Information
2.7.3 Kaketsuken Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Kaketsuken Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Kaketsuken Hepatitis A Vaccine Market Share in 2017
2.8 IMBCA
2.8.1 Business Overview
2.8.1.1 IMBCA Description
2.8.1.2 IMBCA Headquarter, Main Business and Finance Overview
2.8.2 IMBCA Hepatitis A Vaccine Product Introduction
2.8.2.1 Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
2.8.2.2 Hepatitis A Vaccine Product Information
2.8.3 IMBCA Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 IMBCA Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global IMBCA Hepatitis A Vaccine Market Share in 2017
2.9 ChangSheng
2.9.1 Business Overview
2.9.1.1 ChangSheng Description
2.9.1.2 ChangSheng Headquarter, Main Business and Finance Overview
2.9.2 ChangSheng Hepatitis A Vaccine Product Introduction
2.9.2.1 Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
2.9.2.2 Hepatitis A Vaccine Product Information
2.9.3 ChangSheng Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 ChangSheng Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global ChangSheng Hepatitis A Vaccine Market Share in 2017
2.10 Convac
2.10.1 Business Overview
2.10.1.1 Convac Description
2.10.1.2 Convac Headquarter, Main Business and Finance Overview
2.10.2 Convac Hepatitis A Vaccine Product Introduction
2.10.2.1 Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
2.10.2.2 Hepatitis A Vaccine Product Information
2.10.3 Convac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Convac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Convac Hepatitis A Vaccine Market Share in 2017
3 Global Hepatitis A Vaccine Market Competition, by Manufacturer
3.1 Global Hepatitis A Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Hepatitis A Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Hepatitis A Vaccine Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Hepatitis A Vaccine Manufacturer Market Share in 2017
3.4.2 Top 5 Hepatitis A Vaccine Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Hepatitis A Vaccine Market Analysis by Regions
4.1 Global Hepatitis A Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Hepatitis A Vaccine Sales by Regions (2013-2018)
4.1.2 Global Hepatitis A Vaccine Revenue by Regions (2013-2018)
4.2 North America Hepatitis A Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Hepatitis A Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Hepatitis A Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Hepatitis A Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Hepatitis A Vaccine Sales, Revenue and Growth Rate (2013-2018)
5 North America Hepatitis A Vaccine by Countries, Type, Application and Manufacturers
5.1 North America Hepatitis A Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Hepatitis A Vaccine Sales by Countries (2013-2018)
5.1.2 North America Hepatitis A Vaccine Revenue by Countries (2013-2018)
5.1.3 United States Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
5.1.4 Canada Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
5.1.5 Mexico Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
5.2 North America Hepatitis A Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Hepatitis A Vaccine Sales by Manufacturers (2016-2017)
5.2.2 North America Hepatitis A Vaccine Revenue by Manufacturers (2016-2017)
5.3 North America Hepatitis A Vaccine Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Hepatitis A Vaccine Sales and Sales Share by Type (2013-2018)
5.3.2 North America Hepatitis A Vaccine Revenue and Revenue Share by Type (2013-2018)
5.4 North America Hepatitis A Vaccine Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Hepatitis A Vaccine Sales and Sales Share by Application (2013-2018)
5.4.2 North America Hepatitis A Vaccine Revenue and Revenue Share by Application (2013-2018)
6 Europe Hepatitis A Vaccine by Countries, Type, Application and Manufacturers
6.1 Europe Hepatitis A Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Hepatitis A Vaccine Sales by Countries (2013-2018)
6.1.2 Europe Hepatitis A Vaccine Revenue by Countries (2013-2018)
6.1.3 Germany Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
6.1.4 UK Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
6.1.5 France Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
6.1.6 Russia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
6.1.7 Italy Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
6.2 Europe Hepatitis A Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Hepatitis A Vaccine Sales by Manufacturers (2016-2017)
6.2.2 Europe Hepatitis A Vaccine Revenue by Manufacturers (2016-2017)
6.3 Europe Hepatitis A Vaccine Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Hepatitis A Vaccine Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Hepatitis A Vaccine Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Hepatitis A Vaccine Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Hepatitis A Vaccine Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Hepatitis A Vaccine Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Hepatitis A Vaccine by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Hepatitis A Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Hepatitis A Vaccine Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Hepatitis A Vaccine Revenue by Countries (2013-2018)
7.1.3 China Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
7.1.4 Japan Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
7.1.5 Korea Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
7.1.6 India Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Hepatitis A Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Hepatitis A Vaccine Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Hepatitis A Vaccine Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Hepatitis A Vaccine Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Hepatitis A Vaccine Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Hepatitis A Vaccine Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Hepatitis A Vaccine Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Hepatitis A Vaccine Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Hepatitis A Vaccine Revenue and Revenue Share by Application (2013-2018)
8 South America Hepatitis A Vaccine by Countries, Type, Application and Manufacturers
8.1 South America Hepatitis A Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Hepatitis A Vaccine Sales by Countries (2013-2018)
8.1.2 South America Hepatitis A Vaccine Revenue by Countries (2013-2018)
8.1.3 Brazil Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
8.1.4 Argentina Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
8.1.5 Colombia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
8.2 South America Hepatitis A Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Hepatitis A Vaccine Sales by Manufacturers (2016-2017)
8.2.2 South America Hepatitis A Vaccine Revenue by Manufacturers (2016-2017)
8.3 South America Hepatitis A Vaccine Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Hepatitis A Vaccine Sales and Sales Share by Type (2013-2018)
8.3.2 South America Hepatitis A Vaccine Revenue and Revenue Share by Type (2013-2018)
8.4 South America Hepatitis A Vaccine Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Hepatitis A Vaccine Sales and Sales Share by Application (2013-2018)
8.4.2 South America Hepatitis A Vaccine Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Hepatitis A Vaccine by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Hepatitis A Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Hepatitis A Vaccine Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Hepatitis A Vaccine Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
9.1.4 UAE Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
9.1.5 Egypt Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
9.1.7 South Africa Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Hepatitis A Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Hepatitis A Vaccine Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Hepatitis A Vaccine Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Hepatitis A Vaccine Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Hepatitis A Vaccine Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Hepatitis A Vaccine Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Hepatitis A Vaccine Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Hepatitis A Vaccine Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Hepatitis A Vaccine Revenue and Revenue Share by Application (2013-2018)
10 Global Hepatitis A Vaccine Market Segment by Type
10.1 Global Hepatitis A Vaccine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Hepatitis A Vaccine Sales and Market Share by Type (2013-2018)
10.1.2 Global Hepatitis A Vaccine Revenue and Market Share by Type (2013-2018)
10.2 Inactivated Vaccine Sales Growth and Price
10.2.1 Global Inactivated Vaccine Sales Growth (2013-2018)
10.2.2 Global Inactivated Vaccine Price (2013-2018)
10.3 Live Attenuated Vaccine Sales Growth and Price
10.3.1 Global Live Attenuated Vaccine Sales Growth (2013-2018)
10.3.2 Global Live Attenuated Vaccine Price (2013-2018)
11 Global Hepatitis A Vaccine Market Segment by Application
11.1 Global Hepatitis A Vaccine Sales Market Share by Application (2013-2018)
11.2 Government Institution Sales Growth (2013-2018)
11.3 Private Sector Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 Hepatitis A Vaccine Market Forecast (2018-2023)
12.1 Global Hepatitis A Vaccine Sales, Revenue and Growth Rate (2018-2023)
12.2 Hepatitis A Vaccine Market Forecast by Regions (2018-2023)
12.2.1 North America Hepatitis A Vaccine Market Forecast (2018-2023)
12.2.2 Europe Hepatitis A Vaccine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Hepatitis A Vaccine Market Forecast (2018-2023)
12.2.4 South America Hepatitis A Vaccine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Hepatitis A Vaccine Market Forecast (2018-2023)
12.3 Hepatitis A Vaccine Market Forecast by Type (2018-2023)
12.3.1 Global Hepatitis A Vaccine Sales Forecast by Type (2018-2023)
12.3.2 Global Hepatitis A Vaccine Market Share Forecast by Type (2018-2023)
12.4 Hepatitis A Vaccine Market Forecast by Application (2018-2023)
12.4.1 Global Hepatitis A Vaccine Sales Forecast by Application (2018-2023)
12.4.2 Global Hepatitis A Vaccine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Hepatitis A Vaccine Picture
Table Product Specifications of Hepatitis A Vaccine
Figure Global Hepatitis A Vaccine CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Hepatitis A Vaccine CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Hepatitis A Vaccine by Types in 2017
Figure Inactivated Vaccine Picture
Table Major Manufacturers of Inactivated Vaccine
Figure Live Attenuated Vaccine Picture
Table Major Manufacturers of Live Attenuated Vaccine
Figure Hepatitis A Vaccine Sales Market Share by Applications in 2017
Figure Government Institution Picture
Figure Private Sector Picture
Figure Other Picture
Figure United States Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure France Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure UK Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure China Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure India Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Hepatitis A Vaccine Revenue (Value) and Growth Rate (2013-2023)
Table GSK Headquarter, Established, Main Business and Finance Overview (2017)
Table GSK Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
Table GSK Hepatitis A Vaccine Product
Table GSK Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GSK Hepatitis A Vaccine Sales Market Share in 2017
Figure Global GSK Hepatitis A Vaccine Revenue Market Share in 2017
Table Merck Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
Table Merck Hepatitis A Vaccine Product
Table Merck Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck Hepatitis A Vaccine Sales Market Share in 2017
Figure Global Merck Hepatitis A Vaccine Revenue Market Share in 2017
Table Sanofi Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
Table Sanofi Hepatitis A Vaccine Product
Table Sanofi Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Hepatitis A Vaccine Sales Market Share in 2017
Figure Global Sanofi Hepatitis A Vaccine Revenue Market Share in 2017
Table Sinovac Headquarter, Established, Main Business and Finance Overview (2017)
Table Sinovac Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
Table Sinovac Hepatitis A Vaccine Product
Table Sinovac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sinovac Hepatitis A Vaccine Sales Market Share in 2017
Figure Global Sinovac Hepatitis A Vaccine Revenue Market Share in 2017
Table Zhejiang Pukang Headquarter, Established, Main Business and Finance Overview (2017)
Table Zhejiang Pukang Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
Table Zhejiang Pukang Hepatitis A Vaccine Product
Table Zhejiang Pukang Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Zhejiang Pukang Hepatitis A Vaccine Sales Market Share in 2017
Figure Global Zhejiang Pukang Hepatitis A Vaccine Revenue Market Share in 2017
Table Changchun Institute of Biological Headquarter, Established, Main Business and Finance Overview (2017)
Table Changchun Institute of Biological Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
Table Changchun Institute of Biological Hepatitis A Vaccine Product
Table Changchun Institute of Biological Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Changchun Institute of Biological Hepatitis A Vaccine Sales Market Share in 2017
Figure Global Changchun Institute of Biological Hepatitis A Vaccine Revenue Market Share in 2017
Table Kaketsuken Headquarter, Established, Main Business and Finance Overview (2017)
Table Kaketsuken Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
Table Kaketsuken Hepatitis A Vaccine Product
Table Kaketsuken Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Kaketsuken Hepatitis A Vaccine Sales Market Share in 2017
Figure Global Kaketsuken Hepatitis A Vaccine Revenue Market Share in 2017
Table IMBCA Headquarter, Established, Main Business and Finance Overview (2017)
Table IMBCA Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
Table IMBCA Hepatitis A Vaccine Product
Table IMBCA Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global IMBCA Hepatitis A Vaccine Sales Market Share in 2017
Figure Global IMBCA Hepatitis A Vaccine Revenue Market Share in 2017
Table ChangSheng Headquarter, Established, Main Business and Finance Overview (2017)
Table ChangSheng Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
Table ChangSheng Hepatitis A Vaccine Product
Table ChangSheng Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global ChangSheng Hepatitis A Vaccine Sales Market Share in 2017
Figure Global ChangSheng Hepatitis A Vaccine Revenue Market Share in 2017
Table Convac Headquarter, Established, Main Business and Finance Overview (2017)
Table Convac Hepatitis A Vaccine Production Bases, Sales Regions and Major Competitors
Table Convac Hepatitis A Vaccine Product
Table Convac Hepatitis A Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Convac Hepatitis A Vaccine Sales Market Share in 2017
Figure Global Convac Hepatitis A Vaccine Revenue Market Share in 2017
Table Global Hepatitis A Vaccine Sales by Manufacturer (2016-2017)
Figure Global Hepatitis A Vaccine Sales Market Share by Manufacturer in 2016
Figure Global Hepatitis A Vaccine Sales Market Share by Manufacturer in 2017
Table Global Hepatitis A Vaccine Revenue by Manufacturer (2016-2017)
Figure Global Hepatitis A Vaccine Revenue Market Share by Manufacturer in 2016
Figure Global Hepatitis A Vaccine Revenue Market Share by Manufacturer in 2017
Table Global Hepatitis A Vaccine Price by Manufacturer (2016-2017)
Figure Top 3 Hepatitis A Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Hepatitis A Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Global Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
Figure Global Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)
Table Global Hepatitis A Vaccine Sales by Regions (2013-2018)
Table Global Hepatitis A Vaccine Sales Market Share by Regions (2013-2018)
Table Global Hepatitis A Vaccine Revenue by Regions (2013-2018)
Figure Global Hepatitis A Vaccine Revenue Market Share by Regions in 2013
Figure Global Hepatitis A Vaccine Revenue Market Share by Regions in 2017
Figure North America Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
Figure North America Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)
Figure Europe Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
Figure Europe Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)
Figure South America Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
Figure South America Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)
Figure North America Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)
Table North America Hepatitis A Vaccine Sales by Countries (2013-2018)
Table North America Hepatitis A Vaccine Sales Market Share by Countries (2013-2018)
Figure North America Hepatitis A Vaccine Sales Market Share by Countries in 2013
Figure North America Hepatitis A Vaccine Sales Market Share by Countries in 2017
Table North America Hepatitis A Vaccine Revenue by Countries (2013-2018)
Table North America Hepatitis A Vaccine Revenue Market Share by Countries (2013-2018)
Figure North America Hepatitis A Vaccine Revenue Market Share by Countries in 2013
Figure North America Hepatitis A Vaccine Revenue Market Share by Countries in 2017
Figure United States Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
Figure Canada Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
Figure Mexico Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
Table North America Hepatitis A Vaccine Sales by Manufacturer (2016-2017)
Figure North America Hepatitis A Vaccine Sales Market Share by Manufacturer in 2016
Figure North America Hepatitis A Vaccine Sales Market Share by Manufacturer in 2017
Table North America Hepatitis A Vaccine Revenue by Manufacturer (2016-2017)
Figure North America Hepatitis A Vaccine Revenue Market Share by Manufacturer in 2016
Figure North America Hepatitis A Vaccine Revenue Market Share by Manufacturer in 2017
Table North America Hepatitis A Vaccine Sales by Type (2013-2018)
Table North America Hepatitis A Vaccine Sales Share by Type (2013-2018)
Table North America Hepatitis A Vaccine Revenue by Type (2013-2018)
Table North America Hepatitis A Vaccine Revenue Share by Type (2013-2018)
Table North America Hepatitis A Vaccine Sales by Application (2013-2018)
Table North America Hepatitis A Vaccine Sales Share by Application (2013-2018)
Table North America Hepatitis A Vaccine Revenue by Application (2013-2018)
Table North America Hepatitis A Vaccine Revenue Share by Application (2013-2018)
Figure Europe Hepatitis A Vaccine Revenue and Growth Rate (2013-2018)
Table Europe Hepatitis A Vaccine Sales by Countries (2013-2018)
Table Europe Hepatitis A Vaccine Sales Market Share by Countries (2013-2018)
Table Europe Hepatitis A Vaccine Revenue by Countries (2013-2018)
Figure Europe Hepatitis A Vaccine Revenue Market Share by Countries in 2016
Figure Europe Hepatitis A Vaccine Revenue Market Share by Countries in 2017
Figure Germany Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
Figure UK Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
Figure France Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
Figure Russia Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
Figure Italy Hepatitis A Vaccine Sales and Growth Rate (2013-2018)
Table Europe Hepatitis A Vaccine Sales by Manufacturer (2016-2017)
Figure Europe Hepatitis A Vaccine Sales Market Share by Manufacturer in 2016
Figure Europe Hepatitis A Vaccine Sales Market Share by Manufacturer in 2017
Table Europe Hepatitis A Vaccine Revenue by Manufacturer (2016-2017)
Figure Europe Hepatitis A Vaccine Revenue Market Share by Manufacturer in 2016
Figure Europe Hepatitis A Vaccine Revenue Market Share by Manufacturer in 2017
Table Europe Hepatitis A Vaccine Sales by Type (2013-2018)
Table Europe Hepatitis A Vaccine Sales Share by Type (2013-2018)
Table Europe Hepatitis A Vaccine Revenue by Type (2013-2018)
Table Europe Hepatitis A Vaccine Revenue Share by Type (2013-2018)
Table Europe Hepatitis A Vaccine Sales by Application (2013-2018)
Table Europe Hepatitis A Vaccine Sales Share by App
  • Global and Chinese Hepatitis A Vaccine Industry, 2018 Market Research Report
    Published: 14-Dec-2018        Price: US 3000 Onwards        Pages: 145
    The 'Global and Chinese Hepatitis A Vaccine Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Hepatitis A Vaccine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Hepatitis A Vaccine manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry includi......
  • Global and Chinese Hepatitis Drugs Industry, 2018 Market Research Report
    Published: 05-Dec-2018        Price: US 3000 Onwards        Pages: 138
    The 'Global and Chinese Hepatitis Drugs Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Hepatitis Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Hepatitis Drugs manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its defin......
  • Global and Chinese Human Hepatitis B Immunoglobulin Industry, 2018 Market Research Report
    Published: 24-Nov-2018        Price: US 3000 Onwards        Pages: 147
    The 'Global and Chinese Human Hepatitis B Immunoglobulin Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Human Hepatitis B Immunoglobulin industry with a focus on the Chinese market. The report provides key statistics on the market status of the Human Hepatitis B Immunoglobulin manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a......
  • Global Human Hepatitis B Immunoglobulin Market Insights, Forecast to 2025
    Published: 14-Nov-2018        Price: US 3900 Onwards        Pages: 92
    This report studies the global market size of Human Hepatitis B Immunoglobulin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Hepatitis B Immunoglobulin in these regions. This research report categorizes the global Human Hepatitis B Immunoglobulin market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growt......
  • Global and United States Hepatitis A Vaccine Market Research by Company, Type & Application 2013-2025
    Published: 22-Oct-2018        Price: US 2000 Onwards        Pages: 118
    Summary Market Segment as follows: By Type - Liver Inactivated Vaccine - Live Attenuated Vaccine By Application - Hospitals - Other Medical Institutions By Company - GlaxoSmithKline - Merck Sharp & Dohme Corp - SANOFI PASTEUR S.A - Norvatis - Crucell Switzerland AG(Berna+Crucell) - China Academy of Medical Sciences - Changchun Institute of Biological Products -......
  • Global Hepatitis A Vaccine Market Research Report 2018
    Published: 19-Oct-2018        Price: US 2900 Onwards        Pages: 111
    This report studies the global Hepatitis A Vaccine market status and forecast, categorizes the global Hepatitis A Vaccine market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - GlaxoSmithKline - Merck Sharp & Dohme Corp - SANOFI PASTEUR S.A ......
  • Global Hepatitis A Vaccine Market Insights, Forecast to 2025
    Published: 10-Oct-2018        Price: US 3900 Onwards        Pages: 111
    This report studies the global market size of Hepatitis A Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hepatitis A Vaccine in these regions. This research report categorizes the global Hepatitis A Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, ......
  • Global Hepatitis Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-Oct-2018        Price: US 3480 Onwards        Pages: 131
    Hepatitis is an inflammatory condition that occurs due to infection by hepatitis virus. It predominantly affects the liver and also causes damage to other body parts such as digestive system and brain. Apart from viral infections, hepatitis can also be caused by toxic substances, alcohol consumption, and autoimmune diseases. The viruses that cause hepatitis are of several types: A, B, C, D, E, and G. The most common type of hepatitis viruses are A, B, and C. Hepatitis viruses can cause either ac......
  • Global Hepatitis Partnering 2012 to 2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the hepatitis partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Hepatitis Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by valu......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs